Tag for "health" - 蘑菇视频

TAGGED : health

Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial

November 3, 2023

WILMINGTON, Del.--(BUSINESS WIRE)--Nov 3, 2023--Combination of zibotentan with dapagliflozin showed statistically significant and clinically meaningful reductions in urinary albumin-to-creatinine ratio (UACR), used to assess albuminuria, at 12 weeks compared with dapagliflozin alone.After 12 ...

Trailblazing the Future of Healthy Aging Science: Timeline庐 Hosts the First Global Urolithin A Summit With a Full-day Virtual Experience

November 3, 2023

LAUSANNE, Switzerland--(BUSINESS WIRE)--Nov 3, 2023--On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by <a ...

Asia Cervical Cancer Screening Industry Research 2023-2028: Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunities, Competitive Landscape – ResearchAndMarkets.com

November 3, 2023

DUBLIN--(BUSINESS WIRE)--Nov 3, 2023--The <a ...

Sigma Gamma Rho Sorority, Inc. becomes first Divine Nine sorority to raise $1 million for St. Jude Children’s Research Hospital

November 3, 2023

MEMPHIS, Tenn.--(BUSINESS WIRE)--Nov 3, 2023--<a ...

Fall back: How daylight saving time can seriously affect your health

November 3, 2023

CHICAGO (AP) 鈥� Brunch dates and flag football games might be a little easier to get to this Sunday, when phones grace early-risers with an extra hour of rest before alarm clocks go off.The downside: Next week across most of the U.S., the sun will set well before many folks step foot out of ...

Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

November 3, 2023

SEATTLE--(BUSINESS WIRE)--Nov 3, 2023--Omeros Corporation (Nasdaq: OMER) today announced online publication of a report detailing treatment with narsoplimab of 15 adult and pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA), 14 of whom had ...